Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for AstraZeneca
Company Monitoring Page for AstraZeneca
latest headlines for company on cafepharma
AstraZeneca Deepens Gene Editing Capabilities with Revvity Partnership
BioSpace
Thu, 05/18/23 - 11:21 am
Tags:
AstraZeneca
,
Revvity
,
gene editing
,
cell therapy
AstraZeneca's Tagrisso, chemo combination shows promise in lung cancer trial
Yahoo/Reuters
Wed, 05/17/23 - 11:16 am
Tags:
AstraZeneca
,
clinical trials
,
Tagrisso
AstraZeneca is third member to leave PhRMA in five months
Stat
Tue, 05/16/23 - 12:03 pm
Tags:
AstraZeneca
,
lobbying
,
PhRMA
AstraZeneca Expands ADC Portfolio with $600M Deal with LaNova
BioSpace
Mon, 05/15/23 - 06:35 pm
Tags:
AstraZeneca
,
antibody-drug conjugate
,
LaNova Medicines
The waxing and waning of the speedy approval
EP Vantage
Mon, 05/15/23 - 09:58 am
Tags:
FDA
,
drug approvals
,
accelerated approvals
,
AbbVie
,
AstraZeneca
,
Bayer
,
Bristol Myers Squibb
,
JNJ
,
Merck
,
Merck KGaA
,
Novartis
,
Pfizer
Farxiga’s approval for expanded use highlights potential to differentiate in HF space
Clinical Trials Arena
Fri, 05/12/23 - 11:42 am
Tags:
AstraZeneca
,
Farxiga
,
heart failure
2023’s biggest launches: the story so far
EP Vantage
Fri, 05/12/23 - 10:19 am
Tags:
drug launches
,
AbbVie
,
Almirall
,
Apellis Pharmaceuticals
,
Astellas
,
AstraZeneca
,
Biogen
,
CRISPR Therapeutics
,
Daiichi Sankyo
,
Eli Lilly
,
Genmab
,
GSK
,
Iveric Bio
,
Pfizer
,
Roche
,
SAGE Therapeutics
,
Sanofi
,
Sarepta Therapeutics
,
Shionogi
,
Swedish Orphan Biovitrum
,
Vertex Pharmaceuticals
Sanofi, AstraZeneca Report Promising RSV Pediatric Data Ahead of Pfizer Adcomm
BioSpace
Fri, 05/12/23 - 10:16 am
Tags:
Sanofi
,
AstraZeneca
,
RSV
,
antibodies
,
infants
,
clinical trials
A blockbuster year could be building
EP Vantage
Wed, 05/10/23 - 09:55 am
Tags:
AbbVie
,
Amgen
,
AstraZeneca
,
Bristol Myers Squibb
,
Daiichi Sankyo
,
Eli Lilly
,
Gilead Sciences
,
Horizon Therapeutics
,
Merck
,
Moderna Therapeutics
,
Novartis
,
Novo Nordisk
,
Pfizer
,
Regeneron
,
Roche
,
Sanofi
Farxiga Approval Expands Use to More Patients With Heart Failure
eMPR
Tue, 05/9/23 - 11:28 pm
Tags:
AstraZeneca
,
Farxiga
,
FDA
Biopharma Bets Big on Antibody-Drug Conjugates
BioSpace
Mon, 05/8/23 - 10:20 am
Tags:
antibody-drug conjugate
,
Merck
,
Seagen
,
M&A
,
AstraZeneca
,
BioNTech
,
Bristol Myers Squibb
AstraZeneca, Pfizer Top 2023 Pharma List for Invention and Innovation
BioSpace
Sun, 05/7/23 - 10:23 pm
Tags:
reputation
,
AstraZeneca
,
Pfizer
,
innovation
,
IDEA Pharma
AstraZeneca scraps pact with Riva-led Transgene in further blow to oncolytic viruses
Fierce Biotech
Fri, 05/5/23 - 10:18 am
Tags:
AstraZeneca
,
oncolytic viruses
,
Transgene
Bristol Myers accuses AstraZeneca of infringing patent on cancer blockbuster Opdivo—again
Fierce Pharma
Tue, 05/2/23 - 11:29 pm
Tags:
Bristol Myers Squibb
,
Opdivo
,
patents
,
legal
,
AstraZeneca
With negative FDA panel vote, AstraZeneca's Lynparza looks set for narrow nod in prostate cancer
Fierce Pharma
Mon, 05/1/23 - 10:16 am
Tags:
AstraZeneca
,
Merck
,
Lynparza
,
metastatic castration-resistant prostate cancer
FDA Questions Efficacy of Merck-AstraZeneca’s Lynparza Ahead of Adcomm
BioSpace
Thu, 04/27/23 - 10:58 pm
Tags:
Merck
,
AstraZeneca
,
FDA
,
Lynparza
,
metastatic castration-resistant prostate cancer
AstraZeneca dumps $855M, near-approval rare disease drug after talks with regulators
Fierce Biotech
Thu, 04/27/23 - 10:34 am
Tags:
AstraZeneca
,
clinical trials
,
ALXN1840
,
Wilson disease
AstraZeneca overtakes Pfizer as crunch week for UK pharma looms
The Guardian, UK
Tue, 04/25/23 - 10:15 pm
Tags:
AstraZeneca
,
Pfizer
,
earnings
Ionis, AstraZeneca's polyneuropathy med improved patients' quality of life in phase 3, teeing up battle with Alnylam
Fierce Biotech
Mon, 04/24/23 - 10:26 am
Tags:
Ionis Pharmaceuticals
,
AstraZeneca
,
eplontersen
,
Alnylam
,
ATTR
Drugmakers take sides in Amgen, Regeneron fight over antibody patents
BioPharma Dive
Mon, 04/24/23 - 10:17 am
Tags:
Amgen
,
Regeneron Pharmaceuticals
,
Sanofi
,
Supreme Court
,
patents
,
Pfizer
,
Bayer
,
Roche
,
Genentech
,
AstraZeneca
,
JNJ
Pages
« first
‹ previous
…
10
11
12
13
14
15
16
17
18
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
a dog would most likely chase a: cat, rock, house
*
Fill in the blank.